Agilent Technologies Inc

Find Ratings Reports
A : NYSE : Health Care
$60.53 -0.97 | -1.6%
Today's Range: 60.38 - 61.66
Avg. Daily Volume: 2024100.0
07/25/17 - 2:50 PM ET

Financial Analysis


AGILENT TECHNOLOGIES INC's gross profit margin for the second quarter of its fiscal year 2017 is essentially unchanged when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. AGILENT TECHNOLOGIES INC is extremely liquid. Currently, the Quick Ratio is 2.58 which clearly shows the ability to cover any short-term cash needs. A managed to increase the liquidity from the same period a year ago, despite already having very strong liquidity to begin with. This would indicate improved cash flow.

During the same period, stockholders' equity ("net worth") has increased by 5.04% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)1102.01019.0
EBITDA ($mil)262.0218.0
EBIT ($mil)208.0154.0
Net Income ($mil)164.091.0


Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)2389.02139.0
Total Assets ($mil)8016.07640.0
Total Debt ($mil)2043.01889.0
Equity ($mil)4372.04162.0


Profitability Q2 FY17 Q2 FY16
Gross Profit Margin58.8956.92
EBITDA Margin23.7721.39
Operating Margin18.8715.11
Sales Turnover0.540.54
Return on Assets7.236.08
Return on Equity13.2611.22
Debt Q2 FY17 Q2 FY16
Current Ratio3.23.08
Debt/Capital0.320.31
Interest Expense20.018.0
Interest Coverage10.48.56


Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)321.0325.0
Div / share0.130.12
EPS0.50.28
Book value / share13.6212.81
Institutional Own % n/a n/a
Avg Daily Volume2036589.01866224.0

Valuation


BUY. This stock's P/E ratio indicates a significant discount compared to an average of 52.83 for the Life Sciences Tools & Services industry and a premium compared to the S&P 500 average of 24.66. Conducting a second comparison, its price-to-book ratio of 4.48 indicates a premium versus the S&P 500 average of 3.07 and a significant discount versus the industry average of 6.80. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. Upon assessment of these and other key valuation criteria, AGILENT TECHNOLOGIES INC proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
A 34.26 Peers 52.83   A 24.33 Peers 31.49

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

A is trading at a significant discount to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

A is trading at a discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
A 24.39 Peers 29.46   A 0.58 Peers 0.96

Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.

A is trading at a valuation on par with its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

A trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
A 4.48 Peers 6.80   A 26.24 Peers 14.34

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

A is trading at a significant discount to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

A is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
A 4.53 Peers 19.37   A 5.56 Peers 10.10

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

A is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

A significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades